Matthew B. Klein

Insider Reports History

Location
South Plainfield, NJ
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew B. Klein:

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

PTC THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
157,500
Estimated value
$4,733,750
Report date
02 Jan 2026
Price
$27.05
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ClearPoint Neuro, Inc.

Security class
Restricted Stock Units
Shares / value
12,417
Estimated value
$143,432
Report date
22 May 2025
Price
$6.80
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Matthew B. Klein

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .